| Literature DB >> 35087584 |
Zehui Wu1,2, Bing Wang2, Gang Liu2, Jiaju Lu2, Chengxiong Zhang2, Fangzheng Chen2, Lianghui Shi2, Aman Xu1.
Abstract
RESULTS: There were no significant differences between the cRY group and pRY group regarding age, sex, BMI, neoadjuvant therapy, preoperative comorbidities, history of laparotomy, ASA score, tumor location, pathological stage, total operative time, incision length, blood loss, time-to-first flatus, time-to-first soft diet, and postoperative hospital stays. The proportions of patients who received a 21 mm stapler were higher in the cRY group (7/44) than that in the pRY group (0/68) (P = 0.003). 7 anastomotic complications were reported (6 in the cRY group versus 1 in pRY group; P = 0.028) of which five (83.3%) in the cRY were anastomotic stenosis versus none in the pRY group (P = 0.044).Entities:
Year: 2022 PMID: 35087584 PMCID: PMC8789474 DOI: 10.1155/2022/4494401
Source DB: PubMed Journal: Gastroenterol Res Pract ISSN: 1687-6121 Impact factor: 2.260
Figure 1Flowchart of the study.
Figure 2Schematic diagram of pant-shaped anastomosis. A purse-string suture was made on the antimesenteric edge 10 cm away from the jejunal end (a), followed by an incision in its center (b). The two arms of a linear stapler were inserted into the afferent and efferent portion of the jejunum, respectively (c). A circular stapler was inserted into the jejunal pouch through the jejunal end, with the central rod puncturing through the antimesenteric incision (d). After the EJS was finished, the remnant entry was closed using a linear stapler (e), which left the final appearance of the anastomosis similar to a pair of low crotch pants (f).
Figure 3Surgical diagram of pant-shaped anastomosis. A purse-string suture was made on the antimesenteric edge 10 cm away from the jejunal end, followed by an incision in its center (a). The two arms of a linear stapler were inserted into the afferent and efferent portion of the jejunum, respectively (b). A circular stapler was inserted into the jejunal pouch through the jejunal end, with the central rod puncturing through the antimesenteric incision (c). After the EJS was finished, the remnant entry was closed using a linear stapler (d).
Clinicopathological information of the patients in the cRY group and the pRY group.
| Variable | cRY group ( | pRY group ( |
|
|---|---|---|---|
| Age (years) | 62.3 ± 9.1 | 65.2 ± 7.9 | 0.238 |
| Sex(M/F) | 29/15 | 41/27 | 0.468 |
| BMI (kg/m2) | 24.5 ± 2.2 | 24.0 ± 2.1 | 0.197 |
| Neoadjuvant therapy | 5 (11.4%) | 9 (13.2%) | 0.770 |
| Preoperative comorbidities (total) | 16 (36.4%) | 22 (32.3%) | 0.662 |
| Hypertension | 7 (15.9%) | 10 (14.7%) | 0.862 |
| Diabetes mellitus | 4 (9.1%) | 5 (7.4%) | 1.000 |
| Heart disease | 1 (2.3%) | 2 (2.9%) | 1.000 |
| Chronic lung disease | 2 (4.5%) | 3 (4.4%) | 1.000 |
| Other comorbidities | 2 (4.5%) | 2 (2.9%) | 1.000 |
| History of laparotomy | 6 (13.6%) | 8 (11.8%) | 0.770 |
| ASA score (I:II:III) | 25: 17: 2 | 35: 30 : 3 | 0.846 |
| Tumor location | 0.719 | ||
| EGJ | 27 | 44 | |
| Gastric body | 17 | 24 | |
| TNM stagea (I:II:III) | 10: 20: 14 | 7: 38: 23 | 0.191 |
Values are presented as mean ± standard deviation, number, or number (%). ASA score: American Society of Anesthesiologists score; BMI: body mass index; EGJ: esophagogastric junction. aTNM stage was evaluated according to the 8th edition of the AJCC Staging Manual.
Surgical outcomes in the cRY group and the pRY group.
| Variable | cRY group ( | pRY group ( |
|
|---|---|---|---|
| Total operative time (min) | 212.5 ± 16.4 | 213.1 ± 17.5 | 0.859 |
| Operative blood loss (ml) | 39.9 ± 21.0 | 39.6 ± 15.2 | 0.243 |
| Incision length (cm) | 6.9 ± 0.3 | 7.0 ± 0.2 | 0.585 |
| Size of stapler | 0.003∗ | ||
| 25 mm | 37 | 68 | |
| 21 mm | 7 | 0 | |
| Time-to-first flatus | 3.1 ± 0.3 | 3.2 ± 0.4 | 0.309 |
| Time to liquid diet | 4.5 ± 0.5 | 4.4 ± 0.5 | 0.380 |
| Postoperative hospital stay (days) | 12.8 ± 6.4 | 11.8 ± 3.5 | 0.343 |
Values are presented as mean ± standard deviation, number, or number (%). ∗Statistically significant.
Postoperative complications in the cRY group and the pRY group.
| Postoperative complications | cRY group ( | pRY group ( |
|
|---|---|---|---|
| Incision complication | 3 (6.8%) | 4 (5.9%) | 1.000 |
| Postoperative bleeding | 1 (2.3%) | 1 (1.5%) | 1.000 |
| Pulmonary complication | 1 (2.3%) | 1 (1.5%) | 1.000 |
| Anastomotic complications | 6 (13.6%) | 1 (1.5%) | 0.028∗ |
| Anastomotic leakage | 2 (4.5%) | 1 (1.5%) | 0.700 |
| Anastomotic stenosis | 4 (9.1%) | 0 | 0.044∗ |
| Anastomotic bleeding | 0 | 0 | — |
Values are presented as number or number (%). ∗Statistically significant.
The characteristics of cases with anastomotic complications.
| Case number | Anastomotic complication | Anastomosis method | Stapler size | Treatment |
|---|---|---|---|---|
| 1 | Stenosis | cRY | 21 mm | Endoscopic balloon dilation |
| 2 | Stenosis | cRY | 21 mm | Endoscopic balloon dilation |
| 3 | Stenosis | cRY | 21 mm | Endoscopic balloon dilation |
| 4 | Stenosis | cRY | 25 mm | Endoscopic balloon dilation |
| 5 | Leakage | cRY | 21 mm | Conservative treatment |
| 6 | Leakage | cRY | 25 mm | Surgical intervention |
| 7 | Leakage | pRY | 25 mm | Conservative treatment |